Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Sopko

Showing results (51-60 of 166) with videos related to

Pageof 17
Sort By:
Psychosomatic Medicine|March 24, 2006
Depression is associated with cardiac symptoms, mortality risk, and hospitalization among women with suspected coronary disease: the NHLBI-sponsored WISE studyThomas Rutledge, Steven E Reis, Marian Olson, et al.
American Heart Journal|September 20, 2005
Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: the prospective P2C2 HIV Multicenter StudyStacy D Fisher, Kirk A Easley, E John Orav, et al.
The Journal of Clinical Endocrinology and Metabolism|April 6, 2006
Phytoestrogens and lipoproteins in womenC Noel Bairey Merz, B Delia Johnson, Glenn D Braunstein, et al.
Circulation|June 19, 2002
Mild renal insufficiency is associated with angiographic coronary artery disease in womenSteven E Reis, Marian B Olson, Linda Fried, et al.
The American Journal of Medicine|January 23, 2017
Migraine Headache and Long-Term Cardiovascular Outcomes: An Extended Follow-Up of the Women's Ischemia Syndrome EvaluationCecil A Rambarat, Islam Y Elgendy, B Delia Johnson, et al.
American Heart Journal|May 8, 2004
Vascular basis for the treatment of myocardial ischemia study: trial design and baseline characteristicsPeter H Stone, Donald M Lloyd-Jones, Michael Johnstone, et al.
Plos One|December 3, 2020
N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) studyErika Jones, Janet Wei, Michael D Nelson, et al.
Women'S Health (London, England)|September 7, 2013
Clinical implications of the Women's Ischemia Syndrome Evaluation: inter-relationships between symptoms, psychosocial factors and cardiovascular outcomesEileen M Handberg, Jo-Ann Eastwood, Wafia Eteiba, et al.
American Heart Journal|November 18, 2005
Global inflammation predicts cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) studyKevin E Kip, Oscar C Marroquin, Leslee J Shaw, et al.
American Heart Journal Plus : Cardiology Research and Practice|April 8, 2024
Pericardial fat volume is related to endothelial-mediated coronary blood flow in women with suspected coronary microvascular dysfunction. A report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) studySofy Landes, Haider Aldiwani, Louise Thomson, et al.
Pageof 17

Showing results (51-60 of 166) with videos related to

Sort By:
Pageof 17
Psychosomatic Medicine|March 24, 2006
Depression is associated with cardiac symptoms, mortality risk, and hospitalization among women with suspected coronary disease: the NHLBI-sponsored WISE studyThomas Rutledge, Steven E Reis, Marian Olson, et al.
American Heart Journal|September 20, 2005
Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: the prospective P2C2 HIV Multicenter StudyStacy D Fisher, Kirk A Easley, E John Orav, et al.
The Journal of Clinical Endocrinology and Metabolism|April 6, 2006
Phytoestrogens and lipoproteins in womenC Noel Bairey Merz, B Delia Johnson, Glenn D Braunstein, et al.
Circulation|June 19, 2002
Mild renal insufficiency is associated with angiographic coronary artery disease in womenSteven E Reis, Marian B Olson, Linda Fried, et al.
The American Journal of Medicine|January 23, 2017
Migraine Headache and Long-Term Cardiovascular Outcomes: An Extended Follow-Up of the Women's Ischemia Syndrome EvaluationCecil A Rambarat, Islam Y Elgendy, B Delia Johnson, et al.
American Heart Journal|May 8, 2004
Vascular basis for the treatment of myocardial ischemia study: trial design and baseline characteristicsPeter H Stone, Donald M Lloyd-Jones, Michael Johnstone, et al.
Plos One|December 3, 2020
N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) studyErika Jones, Janet Wei, Michael D Nelson, et al.
Women'S Health (London, England)|September 7, 2013
Clinical implications of the Women's Ischemia Syndrome Evaluation: inter-relationships between symptoms, psychosocial factors and cardiovascular outcomesEileen M Handberg, Jo-Ann Eastwood, Wafia Eteiba, et al.
American Heart Journal|November 18, 2005
Global inflammation predicts cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) studyKevin E Kip, Oscar C Marroquin, Leslee J Shaw, et al.
American Heart Journal Plus : Cardiology Research and Practice|April 8, 2024
Pericardial fat volume is related to endothelial-mediated coronary blood flow in women with suspected coronary microvascular dysfunction. A report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) studySofy Landes, Haider Aldiwani, Louise Thomson, et al.
Pageof 17